Owners and management
CVR: 46220080
Not available
Science Studio Holding ApS (25-33,32%), Nordic Alchemy Holding ApS (25-33,32%)
3 more
CVR · view owners
Maja Storm Engelstoft
CVR · view management
Active
Founded 30 January 2026
CVR · view overview
6 employees
CVR · 2026
Director role ended: Christoffer Clemmensen
CVR · 01/05/2026
View the full event history
Heureka Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2026. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Maja Storm Engelstoft. The company's owners include Science Studio Holding ApS, Nordic Alchemy Holding ApS and mol.bio Holding ApS. The company has 6 employees (2026).
Selskabets formål er at drive forskning og udvikling inden for bioteknologi og lægemiddeludvikling, herunder identifikation, udvikling og kommercialisering af terapeutiske kandidater samt aktiviteter relateret hertil.
No annual financial figures are available for this company.
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorThe CVR number of Heureka Therapeutics ApS is 46220080.
The owners of Heureka Therapeutics ApS include Science Studio Holding ApS, Nordic Alchemy Holding ApS and mol.bio Holding ApS.
The management of Heureka Therapeutics ApS consists of Maja Storm Engelstoft.
Heureka Therapeutics ApS had 6 employees in 2026 according to the Danish CVR register.
Heureka Therapeutics ApS was founded on 30 January 2026.
Heureka Therapeutics ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
Claim this page to add your logo and social links. Free to get started.
As of May 1, 2026, Maja Storm Engelstoft is registered as adm. dir. of Heureka Therapeutics ApS.
As of May 1, 2026, Christoffer Clemmensen has stepped down as director of Heureka Therapeutics ApS.
As of May 1, 2026, Jonas Odgaard Petersen has stepped down as director of Heureka Therapeutics ApS.
As of April 29, 2026, Science Studio Holding ApS is registered as an owner of Heureka Therapeutics ApS with an ownership share of 25%.
As of April 29, 2026, Nordic Alchemy Holding ApS is registered as an owner of Heureka Therapeutics ApS with an ownership share of 25%.
As of April 29, 2026, Engelstoft Holding ApS is registered as an owner of Heureka Therapeutics ApS with an ownership share of 10%.
As of January 30, 2026, Christoffer Clemmensen is registered as director of Heureka Therapeutics ApS.
As of January 30, 2026, Jonas Odgaard Petersen is registered as director of Heureka Therapeutics ApS.
As of January 30, 2026, mol.bio Holding ApS is registered as an owner of Heureka Therapeutics ApS with an ownership share of 10%.
As of January 30, 2026, Ichiban Bio ApS is registered as an owner of Heureka Therapeutics ApS with an ownership share of 20%.
Heureka Therapeutics ApS was founded on January 30, 2026.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Companies in the same industry and area
CVR 36465972
CVR 45436497
CVR 46059220
CVR 41978074
CVR 46543912
